Tag: Mental health
Mind Cure Releases iSTRYM: A Digital Platform for Mental Health and Psychedelic Research
Canadian mental health firm Mind Cure has released a digital therapeutic tool designed to close the gaps between patients, clinicians and researchers. The app,...
Moodbeam Receives $583k Seed investment To Boost Workplace Wellbeing
Moodbeam, a Hull-based health tech start-up, which produces wearable mental wellbeing devices, has received £450k (US$583k) in investment. It follows two rounds of investment totaling £450,000 from NPIF-Mercia Equity Finance, […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Swedish Startup Flow’s Mental Health App Now Available For NHS Recommendations
An app by Swedish mental health startup Flow has joined the ORCHA app library. The inclusion means that many NHS Trusts and healthcare professionals, who have their own App Library […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Our Negative Emotions Have Almost Doubled Since Lockdown, Reveals Sentio’s Wearable Sensor
Objective data collected by Sentio Solutions’ Feel Emotion Sensor showed that COVID-19 lockdown has prompted our negative emotions to dramatically increase. For the first time in the mental health industry, […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
LivaNova’s VNS Therapy System Receives CE Mark for Difficult-to-Treat Depression
LivaNova, a leading medical technology and innovation company, based in London, announced its Vagus Nerve Stimulation Therapy® (VNS Therapy) System, Symmetry™, earned CE Mark approval for Difficult-to-Treat Depression (DTD). Two […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).
Proteus Ends Deal with Otsuka, Refocuses on Oncology and Infectious Diseases Treatment
Proteus has prematurely ended its high profile $88 million deal with Otsuka, reports MobiHealthNews. Proteus’ CEO, Andrew Thompson, told STAT News that the company and Otsuka Pharmaceutical have ended a […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).